UDG Healthcare plc
("UDG" or "the Company")
28 January 2021
Directorate Changes
Following a review of the composition of the Board Committees, UDG is pleased to announce the following Committee changes, all of which are effective from 1 February 2021:
Nominations, Governance & Sustainability Committee
Linda Wilding will step down from the Nominations, Governance & Sustainability Committee and Peter Chambré and Anne Whitaker will be appointed to this Committee.
Risk, Investment & Financing Committee
Shane Cooke will step down as Chair of the Risk, Investment & Financing Committee and will be replaced as Chair by Linda Wilding. Lisa Ricciardi will also step down from this Committee, with Liz Shanahan and Anne Whitaker being appointed to the Committee.
Remuneration Committee
Linda Wilding will step down as Chair of the Remuneration Committee and Peter Chambré will assume the role of Chair. Lisa Ricciardi will also step down as a member of the Remuneration Committee and Erik Van Snippenberg and Anne Whitaker will be appointed to this Committee.
Details of the composition of each Committee are available on our website at https://www.udghealthcare.com/investors/corporate-governance/board-committees/.
This announcement is made in accordance with Listing Rule 9.6.11(3).
For further information, please contact:
UDG Healthcare plc
Damien Moynagh
General Counsel & Company Secretary
+353 (1) 468 9000
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
